By Michelle Morgante | August 22, 2024
California-based Amgen has filed a patent infringement suit to stop Samsung Bioepis from developing bone-treatment drugs that would rival two of its top-performing products.
By Charles Toutant | July 25, 2024
The suits stem from defendants' submission to the U.S. Food and Drug Administration of Abbreviated New Drug Applications [ANDA] seeking permission to manufacture generic versions of American Regent's selenious acid products before their patents expire.
New Jersey Law Journal | Commentary
By James L. Ryerson | July 24, 2024
"Whether the 'new' standard will prove significantly less stringent in practice is just one of many open questions," writes Greenberg Traurig's James Ryerson.
New Jersey Law Journal | Commentary
By Peter J. Butch III and Howard S. Suh | July 2, 2024
"Innovator companies should expect Orange Book patent listing challenges to emerge as an additional and simpler tool for overcoming ANDA litigation," write Peter J. Butch III and Howard S. Suh.
By Charles Toutant | May 30, 2024
Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.
By Chris O'Malley | April 25, 2024
"Nonsolicitation agreements will be that much more important, that much more of a prevalent part of how private entities regulate ... or manage the market for employment and employment mobility," said John Siegal, a Baker & Hostetler partner.
New Jersey Law Journal | Analysis|News
By Amanda O'Brien | March 28, 2024
While sources pointed to failed discussions over how to transition beyond the leadership of founding partners Angelo Genova and James Burns, Burns said the firm has "built a brand which will continue beyond its founders."
New Jersey Law Journal | Commentary
By Jeffrey Weinick and Drew Berweger | March 27, 2024
"Where is the line between AI rising to the role of inventor and mere AI assistance for human inventors?" write Jeffrey Weinick and Drew Berweger of CSG Law's patent group.
By Charles Toutant | January 3, 2024
"This disappointing decision is based on legal and factual errors we are confident will be reversed on appeal," Joseph K. Belanoff, Corcept's CEO, said in a statement.
By Emily Saul | November 22, 2023
"OpenAI and Microsoft have built a business valued into the tens of billions of dollars by taking the combined works of humanity without permission," reads the proposed class action filed on behalf of nonfiction author Julian Sancton.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Javerbaum Wurgaft, a large civil litigation firm with nine (9) offices, seeks: Plaintiff Personal Injury Attorney for Northern New Jersey of...
Exciting Career Opportunities at Nuzzo & Roberts! Nuzzo & Roberts, a leading mid-sized insurance defense firm based in Cheshire, CT...